baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

PDS Biotechnology Corp/ US70465T1079 /

2024-06-05 9:59:52 PM	Chg. +0.12	Volume	Bid-	Ask-	High	Low
3.02USD	+3.97%	17,073 Turnover: 50,291.06	-Bid Size: -	-Ask Size: -	3.04	2.85

GlobeNewswire 05-15 PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 05-09 PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurre...

GlobeNewswire 05-09 PDS Biotech to Participate in Upcoming May 2024 Investor Conferences

GlobeNewswire 05-07 PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024

GlobeNewswire 05-03 PDS Biotechnology Announces Details of Virtual KOL Event

GlobeNewswire 05-02 PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

GlobeNewswire 04-23 PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATIL...

GlobeNewswire 03-27 PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results

GlobeNewswire 03-20 PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Finan...

GlobeNewswire 03-13 PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Pa...

GlobeNewswire 01-22 PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., ...

GlobeNewswire 01-16 PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire 2023-12-04 PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2023-11-28 PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer

GlobeNewswire 2023-11-14 PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 2023-11-09 PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Tri...

GlobeNewswire 2023-11-07 PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results

GlobeNewswire 2023-10-23 PDS Biotech Announces Preliminary Biomarker Study Results in Subset of Advanced HPV-Positive Head an...

GlobeNewswire 2023-10-11 PDS Biotech Announces Interim Safety and Immune Response Data from Phase 1/2 Clinical Trial Evaluati...

GlobeNewswire 2023-10-03 PDS Biotech Announces Interim 24-Month Survival Rate of 74% in Immune Checkpoint Inhibitor Naïve Hea...

GlobeNewswire 2023-10-02 PDS Biotech Announces PDS0101 Combined with Chemoradiotherapy Associated with Rapid Decline in Circu...

GlobeNewswire 2023-09-26 PDS Biotech to Present at the LD Micro Main Event XVI

GlobeNewswire 2023-09-25 PDS Biotech Reschedules Key Opinion Leader Roundtable Addressing Current and Future Treatments for R...

GlobeNewswire 2023-09-20 PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire 2023-09-20 PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclin...

PDS Biotechnology Corp/ US70465T1079 /

If you wish to receive reply to your feedback, please provide your email address.